ARIC Publications
"The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators." Am J Epidemiol. 1989;129(4):687-702.
The Atherosclerosis Risk in Communities (ARIC) Study. Introduction and objectives of the hemostasis component." Ann Epidemiol. 1992;2(4):467-9.
"Atrial Fibrillation and Brain Magnetic Resonance Imaging Abnormalities." Stroke. 2019;50(4):783-788.
"Atrial fibrillation and cognitive decline-the role of subclinical cerebral infarcts: the atherosclerosis risk in communities study." Stroke. 2014;45(9):2568-74.
"Atrial Fibrillation and Dementia: A Report From the AF-SCREEN International Collaboration." Circulation. 2022;145(5):392-409.
"Atrial Fibrillation and Ischemic Stroke With the Amyloidogenic V122I Transthyretin Variant Among Black Americans." J Am Coll Cardiol. 2021;78(1):89-91.
"Atrial Fibrillation and Risk of ST-Segment-Elevation Versus Non-ST-Segment-Elevation Myocardial Infarction: The Atherosclerosis Risk in Communities (ARIC) Study." Circulation. 2015;131(21):1843-50.
"Atrial fibrillation and the risk of sudden cardiac death: the atherosclerosis risk in communities study and cardiovascular health study." JAMA Intern Med. 2013;173(1):29-35.
"Atrial fibrillation and venous thromboembolism: evidence of bidirectionality in the Atherosclerosis Risk in Communities Study." J Thromb Haemost. 2018;16(4):670-679.
"Atrial Fibrillation, Brain Volumes, and Subclinical Cerebrovascular Disease (from the Atherosclerosis Risk in Communities Neurocognitive Study [ARIC-NCS])." Am J Cardiol. 2020;125(2):222-228.
"B vitamin status and inflammatory markers." Atherosclerosis. 2003;169(1):169-74.
"Baldness and myocardial infarction in men: the atherosclerosis risk in communities study." Am J Epidemiol. 2008;167(6):676-83.
"A Bayesian Partitioning Model for the Detection of Multilocus Effects in Case-Control Studies." Hum Hered. 2015;79(2):69-79.
"Beat-to-beat spatiotemporal variability in the T vector is associated with sudden cardiac death in participants without left ventricular hypertrophy: the Atherosclerosis Risk in Communities (ARIC) Study." J Am Heart Assoc. 2015;4(1):e001357.
"Best practices and joint calling of the HumanExome BeadChip: the CHARGE Consortium." PLoS One. 2013;8(7):e68095.
"Beta2-adrenergic receptor genetic variants and risk of sudden cardiac death." Circulation. 2006;113(15):1842-8.
"Beta3-adrenergic receptor Trp64Arg polymorphism does not predict incident CHD or carotid intima-media thickness in a community-based sample of whites: the ARIC study. Atherosclerosis Risk in Communities." Hum Genet. 1999;105(4):314-9.
"Beta-fibrinogen gene -455G/A polymorphism and coronary heart disease incidence: the Atherosclerosis Risk in Communities (ARIC) Study." Ann Epidemiol. 2001;11(3):166-70.
"Bias Correction Methods for Misclassified Covariates in the Cox Model: comparison offive correction methods by simulation and data analysis." J Stat Theory Pract. 2013;7(2):381-400.
"Bias in estimating the cross-sectional smoking, alcohol, obesity and diabetes associations with moderate-severe periodontitis in the Atherosclerosis Risk in Communities study: comparison of full versus partial-mouth estimates." J Clin Periodontol. 2015;42(7):609-21.
"A bidirectional Mendelian randomization study supports causal effects of kidney function on blood pressure." Kidney Int. 2020;98(3):708-716.
"BinomiRare: A robust test for association of a rare genetic variant with a binary outcome for mixed models and any case-control proportion." HGG Adv. 2021;2(3).
"A bioinformatics pipeline for estimating mitochondrial DNA copy number and heteroplasmy levels from whole genome sequencing data." NAR Genom Bioinform. 2022;4(2):lqac034.
"Biological, clinical and population relevance of 95 loci for blood lipids." Nature. 2010;466(7307):707-13.
"Biological knowledge-driven analysis of epistasis in human GWAS with application to lipid traits." Methods Mol Biol. 2015;1253:35-45.
"Biomarker-Based Risk Prediction of Incident Heart Failure in Pre-Diabetes and Diabetes." JACC Heart Fail. 2021;9(3):215-223.
"Biomarkers and degree of atherosclerosis are independently associated with incident atherosclerotic cardiovascular disease in a primary prevention cohort: The ARIC study." Atherosclerosis. 2016;253:156-163.
"Biomarkers of Mineral and Bone Metabolism and 20-Year Risk of Hospitalization With Infection: The Atherosclerosis Risk in Communities Study." J Clin Endocrinol Metab. 2017;102(12):4648-4657.
"Biomarkers of Vitamin D Status and Risk of ESRD." Am J Kidney Dis. 2016;67(2):235-42.
"Birth weight and the risk of atrial fibrillation in whites and African Americans: the Atherosclerosis Risk In Communities (ARIC) study." BMC Cardiovasc Disord. 2014;14:69.
"A bivariate genome-wide approach to metabolic syndrome: STAMPEED consortium." Diabetes. 2011;60(4):1329-39.
"Black-white differences in electrocardiographic left ventricular mass and its association with blood pressure (the ARIC study). Atherosclerosis Risk in Communities." Am J Cardiol. 1994;74(3):247-52.
"Blood DNA Methylation and Incident Coronary Heart Disease: Evidence From the Strong Heart Study." JAMA Cardiol. 2021.
"Blood DNA methylation sites predict death risk in a longitudinal study of 12, 300 individuals." Aging (Albany NY). 2020;12(14):14092-14124.
"Blood Leukocyte DNA Methylation Predicts Risk of Future Myocardial Infarction and Coronary Heart Disease." Circulation. 2019;140(8):645-657.
"Blood lipid levels, lipid-lowering medications, and the incidence of atrial fibrillation: the atherosclerosis risk in communities study." Circ Arrhythm Electrophysiol. 2012;5(1):155-62.
"Blood metabolites predicting mild cognitive impairment in the study of Latinos-investigation of neurocognitive aging (HCHS/SOL)." Alzheimers Dement (Amst). 2022;14(1):e12259.
"Blood Pressure and Later-Life Cognition in Hispanic and White Adults (BP-COG): A Pooled Cohort Analysis of ARIC, CARDIA, CHS, FOS, MESA, and NOMAS." J Alzheimers Dis. 2022.
"Blood pressure and menopausal transition: the Atherosclerosis Risk in Communities study (1987-95)." J Hypertens. 2000;18(1):27-33.
"Blood pressure and the risk of developing diabetes in african americans and whites: ARIC, CARDIA, and the framingham heart study." Diabetes Care. 2011;34(4):873-9.
"Blood pressure and white-matter disease progression in a biethnic cohort: Atherosclerosis Risk in Communities (ARIC) study." Stroke. 2010;41(1):3-8.
"Blood pressure, atherosclerosis, and albuminuria in 10,113 participants in the atherosclerosis risk in communities study." J Hypertens. 2009;27(2):397-409.
"Blood pressure usually considered normal is associated with an elevated risk of cardiovascular disease." Am J Med. 2006;119(2):133-41.
"Blood viscosity and hematocrit as risk factors for type 2 diabetes mellitus: the atherosclerosis risk in communities (ARIC) study." Am J Epidemiol. 2008;168(10):1153-60.
"B-mode ultrasound-detected carotid artery lesions with and without acoustic shadowing and their association with markers of inflammation and endothelial activation: the atherosclerosis risk in communities study." Atherosclerosis. 2002;162(1):145-55.
"B-mode-detected carotid artery plaque in a general population. Atherosclerosis Risk in Communities (ARIC) Study Investigators." Stroke. 1994;25(12):2377-83.
"BNP and obesity in acute decompensated heart failure with preserved vs. reduced ejection fraction: The Atherosclerosis Risk in Communities Surveillance Study." Int J Cardiol. 2017;233:61-66.
"Body mass index and blood pressure influences on left ventricular mass and geometry in African Americans: The Atherosclerotic Risk In Communities (ARIC) Study." Hypertension. 2004;44(1):55-60.
"Body mass index at age 25 and all-cause mortality in whites and African Americans: the Atherosclerosis Risk in Communities study." J Adolesc Health. 2012;50(3):221-7.
"Body mass index prediction rule for mid-upper arm circumference: the atherosclerosis risk in communities study." Blood Press Monit. 2021.
"Body mass index, waist/hip ratio, and coronary heart disease incidence in African Americans and whites. Atherosclerosis Risk in Communities Study Investigators." Am J Epidemiol. 1998;148(12):1187-94.
"Body size measures, hemostatic and inflammatory markers and risk of venous thrombosis: The Longitudinal Investigation of Thromboembolism Etiology." Thromb Res. 2016;144:127-32.
"Body weight change and carotid artery wall thickness. The Atherosclerosis Risk in Communities (ARIC) Study." Am J Epidemiol. 1998;147(6):563-73.
"Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents." Lancet. 2016;388(10046):776-86.
"Brain Aging in African-Americans: The Atherosclerosis Risk in Communities (ARIC) Experience." Curr Alzheimer Res. 2015;12(7):607-13.
"Brain function and structure and risk for incident diabetes: The Atherosclerosis Risk in Communities Study." Alzheimers Dement. 2017;13(12):1345-1354.
"Brain Imaging Features Associated with 20-Year Cognitive Decline in a Community-Based Multiethnic Cohort without Dementia." Neuroepidemiology. 2022;56(3):183-191.
"Brain White Matter Structure and Amyloid Deposition in Black and White Older Adults: The ARIC-PET Study." J Am Heart Assoc. 2021;10(17):e022087.
"Bringing Critical Race Praxis Into the Study of Electrophysiological Substrate of Sudden Cardiac Death: The ARIC Study." J Am Heart Assoc. 2020;9(3):e015012.
"B-type natriuretic peptide and C-reactive protein in the prediction of atrial fibrillation risk: the CHARGE-AF Consortium of community-based cohort studies." Europace. 2014;16(10):1426-33.
"Bundle branch blocks and the risk of mortality in the Atherosclerosis Risk in Communities study." J Cardiovasc Med (Hagerstown). 2016;17(6):411-7.
"Burden of rare exome sequence variants in PROC gene is associated with venous thromboembolism: a population-based study." J Thromb Haemost. 2020;18(2):445-453.
"Can postmenopausal hormone replacement improve plasma lipids in women with diabetes? The Atherosclerosis Risk in Communities Study Investigators." Diabetes Care. 1996;19(5):480-5.
"Cancer Survivorship and Subclinical Myocardial Damage." Am J Epidemiol. 2019;188(12):2188-2195.
"Carbohydrate intake modifies associations between ANGPTL4[E40K] genotype and HDL-cholesterol concentrations in White men from the Atherosclerosis Risk in Communities (ARIC) study." Atherosclerosis. 2009;203(1):214-20.
"Carboxymethyl lysine, an advanced glycation end product, and incident diabetes: a case-cohort analysis of the ARIC Study." Diabet Med. 2016;33(10):1392-8.
"Cardiac and kidney markers for cardiovascular prediction in individuals with chronic kidney disease: the Atherosclerosis Risk in Communities study." Arterioscler Thromb Vasc Biol. 2014;34(8):1770-7.
"Cardiac Autonomic Dysfunction and Incidence of Atrial Fibrillation: Results From 20 Years Follow-Up." J Am Coll Cardiol. 2017;69(3):291-299.
"Cardiac autonomic function and incident coronary heart disease: a population-based case-cohort study. The ARIC Study. Atherosclerosis Risk in Communities Study." Am J Epidemiol. 1997;145(8):696-706.
"Cardiac Biomarkers and Subsequent Risk of Hospitalization With Bleeding in the Community: Atherosclerosis Risk in Communities Study." J Am Heart Assoc. 2020;9(5):e013560.
"Cardiac structure and function across the glycemic spectrum in elderly men and women free of prevalent heart disease: the Atherosclerosis Risk In the Community study." Circ Heart Fail. 2015;8(3):448-54.
"Cardiac Structure and Function Across the Spectrum of Aldosteronism: the Atherosclerosis Risk in Communities Study." Hypertension. 2022;79(9):1984-1993.
"Cardiac Structure and Function and Diabetes-Related Risk of Death or Heart Failure in Older Adults." J Am Heart Assoc. 2022;11(6):e022308.
"Cardiac structure and function and leisure-time physical activity in the elderly: The Atherosclerosis Risk in Communities Study." Eur Heart J. 2016;37(32):2544-51.
"Cardiac troponin T measured by a highly sensitive assay predicts coronary heart disease, heart failure, and mortality in the Atherosclerosis Risk in Communities Study." Circulation. 2011;123(13):1367-76.
"Cardio-ankle vascular index and cardiovascular disease: Systematic review and meta-analysis of prospective and cross-sectional studies." J Clin Hypertens (Greenwich). 2019;21(1):16-24.
""Cardiometabolic effects of genetic upregulation of the interleukin 1 receptor antagonist: a Mendelian randomisation analysis." Lancet Diabetes Endocrinol. 2015;3(4):243-53.
Cardiometabolic risk in impaired fasting glucose and impaired glucose tolerance: the Atherosclerosis Risk in Communities Study." Diabetes Care. 2007;30(2):325-31.
"Cardiovascular biomarkers and subclinical brain disease in the atherosclerosis risk in communities study." Stroke. 2013;44(7):1803-8.
" "